Eli Lilly and Company, UnitedHealth Group, ProKidney, Hims & Hers Health, Walmart, Pfizer, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies engaged in the research, development, manufacture or distribution of medical products and services. This category includes firms that make pharmaceuticals, medical devices, diagnostics, biotechnology innovations, hospital services and other healthcare‐related offerings. Investors in medical stocks seek exposure to the healthcare sector’s growth drivers—such as demographic trends, technological advances and ongoing medical needs. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY stock traded up $3.76 during trading on Tuesday, hitting $776.63. The company had a trading volume of 1,948,095 shares, compared to its average volume of 3,657,223. The stock's 50-day moving average is $771.52 and its two-hundred day moving average is $800.30. The stock has a market capitalization of $736.04 billion, a price-to-earnings ratio of 63.19, a price-to-earnings-growth ratio of 1.14 and a beta of 0.40. The company has a quick ratio of 1.06, a current ratio of 1.37 and a debt-to-equity ratio of 2.18. Eli Lilly and Company has a 52 week low of $677.09 and a 52 week high of $972.53.
Read Our Latest Research Report on LLY
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of NYSE:UNH traded up $1.68 during trading on Tuesday, reaching $305.39. The company had a trading volume of 4,591,383 shares, compared to its average volume of 7,554,524. The stock has a market capitalization of $277.03 billion, a P/E ratio of 12.79, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a fifty day moving average of $322.66 and a two-hundred day moving average of $445.65.
Read Our Latest Research Report on UNH
ProKidney (PROK)
ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease.
PROK traded up $3.60 during trading on Tuesday, reaching $4.21. The stock had a trading volume of 275,708,046 shares, compared to its average volume of 2,939,814. The business has a 50-day moving average of $0.77 and a 200-day moving average of $1.10. ProKidney has a one year low of $0.46 and a one year high of $4.21. The stock has a market cap of $1.23 billion, a PE ratio of -7.02 and a beta of 1.26.
Read Our Latest Research Report on PROK
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
NYSE:HIMS traded up $1.82 during mid-day trading on Tuesday, reaching $50.24. The stock had a trading volume of 18,028,712 shares, compared to its average volume of 23,468,766. The stock has a market capitalization of $11.25 billion, a P/E ratio of 72.81, a P/E/G ratio of 1.76 and a beta of 2.02. The firm has a 50 day moving average price of $52.62 and a two-hundred day moving average price of $40.54. Hims & Hers Health has a one year low of $13.47 and a one year high of $72.98.
Read Our Latest Research Report on HIMS
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Shares of Walmart stock traded down $1.47 during trading on Tuesday, reaching $97.88. The company's stock had a trading volume of 7,692,785 shares, compared to its average volume of 18,008,272. The company has a quick ratio of 0.22, a current ratio of 0.78 and a debt-to-equity ratio of 0.47. Walmart has a 52-week low of $66.67 and a 52-week high of $105.30. The firm's 50-day moving average is $97.22 and its two-hundred day moving average is $94.41. The company has a market cap of $781.12 billion, a price-to-earnings ratio of 41.83, a PEG ratio of 4.73 and a beta of 0.68.
Read Our Latest Research Report on WMT
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Shares of PFE traded up $0.18 during trading hours on Tuesday, hitting $25.42. The company had a trading volume of 29,086,303 shares, compared to its average volume of 41,652,449. The firm has a market cap of $144.52 billion, a P/E ratio of 18.42, a P/E/G ratio of 0.92 and a beta of 0.58. Pfizer has a 52-week low of $20.92 and a 52-week high of $31.54. The stock's 50 day moving average price is $23.76 and its 200 day moving average price is $24.81. The company has a quick ratio of 0.96, a current ratio of 1.26 and a debt-to-equity ratio of 0.64.
Read Our Latest Research Report on PFE
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Merck & Co., Inc. stock traded down $0.04 during trading hours on Tuesday, reaching $80.86. The company had a trading volume of 7,741,600 shares, compared to its average volume of 13,271,330. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.41 and a quick ratio of 1.16. Merck & Co., Inc. has a 12-month low of $73.31 and a 12-month high of $129.93. The company has a 50-day moving average price of $79.15 and a 200 day moving average price of $86.77. The firm has a market cap of $203.04 billion, a price-to-earnings ratio of 11.77, a P/E/G ratio of 0.84 and a beta of 0.39.
Read Our Latest Research Report on MRK
Read More
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
